There is often mutual regulation among immune checkpoints in the TIME [18,19,20], which prompted us to further evaluate the PD-1, PD-L1, and CTLA4 protein levels in the tumor tissues using IHC after anti-CD47 Ab treatment. This evidence concerns the gene CD47 and neoplasm.